Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: The experience of the Italian immuno-pathology group

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 4, 2016, Pages 655-658

  Quaglino, P ^a   Fava, P ^a   Caproni, M ^b   Antiga, E ^b   De Simone, C ^c   Papini, M ^d   Parodi, A ^e   Novelli, M ^a   Osella Abate, S ^a   Ribero, S ^a   Sanlorenzo, M ^a   Ponti, R ^a   Fierro, M T ^a   Marzano, A V ^f   Savoia, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d University of Terni   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; MIDDLE AGED; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYODERMA GANGRENOSUM; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; YOUNG ADULT; ADOLESCENT; BLOOD; IMMUNOLOGY; ITALY; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; FEMALE; FLOW CYTOMETRY; HUMANS; ITALY; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84962091065     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13100     Document Type: Article

References (22)

1. Wollina U, Haroske G,. Pyoderma gangrenosum. Curr Opin Rheumatol 2011; 23: 50-56.
2. Ahronowitz I, Harp J, Shinkai K,. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 2012; 13: 191-211.
3. Marzano AV, Menicanti C, Crosti C, Trevisan V,. Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 2013; 148: 185-196.
4. Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M,. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 2013; 45: 202-210.
5. Marzano AV, Cugno M, Trevisan V, et al,. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162: 100-107.
6. Brooklyn TN, Williams AM, Dunnill MG, Probert GS,. T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansion and trafficking. Br J Dermatol 2007; 157: 960-966.
7. Marzano AV, Fanoni D, Antiga E, et al,. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and sweet's syndrome. Clin Exp Immunol 2014; 178: 48-56.
8. Marzano AV, Trevisan V, Lazzari R, Crosti C,. Pyoderma gangrenosum: study of 21 patients and proposal of a "clinicotherapeutic" classification. J Dermatolog Treat 2011; 22: 254-260.
9. Rovati B, Mariucci S, Manzoni M, Bencardino K, Danova M,. Flow-cytometric detection of circulating dendritic cells in healthy subjects. Eur J Histochem 2008; 52: 45-52.
10. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA,. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
11. Bonecchi R, Bianchi G, Bordignon PP, et al,. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-134.
12. Maggi L, Santarlasci V, Capone M, et al,. Distinctive features of classic and non classic (Th17 derived) human Th1 cells. Eur J Immunol 2012; 42: 3180-3188.
13. Fischer-Stabauer M, Boehner A, Eyerich S, et al,. Differential in situ expression of IL-17 in skin diseases. Eur J Dermatol 2012; 22: 781-784.
14. Guenova E, Teske A, Fehrenbacher B, et al,. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol 2011; 147: 1203-1205.
15. Caproni M, Antiga E, Volpi W, et al,. The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum. Br J Dermatol 2015; doi: 10.1111/bjd.13670 [Epub ahead of print]
16. Rissoan MC, Soumelis V, Kadowaki N, et al,. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183-1186.
17. Pellerin L, Jenks JA, Bégin P, Bacchetta R, Nadeau KC,. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014; 58: 358-368.
18. Quaglino P, Ortoncelli M, Comessatti A, et al,. Circulating CD4+ CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 2009; 219: 250-258.
19. Quaglino P, Ponti R, Novelli M, et al,. Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses. G Ital Dermatol Venereol 2013; 148: 197-201.
20. Zheng SG,. Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? Am J Clin Exp Immunol 2013; 2: 94-106.
21. Quaglino P, Bergallo M, Ponti R, et al,. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology 2011; 223: 57-67.
22. Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ,. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 2011; 131: 1853-1860.